Tailored Systemic Therapy for Colorectal Cancer Liver Metastases
Liver metastases are the most common site of metastatic spread in colorectal cancer. Current treatment approaches involve effective systemic therapies in combination with surgical and/or interventional strategies. Multimodal strategies greatly improved clinical outcomes of patients with metastatic c...
Saved in:
Main Authors: | Carolin Czauderna, Kim Luley, Nikolas von Bubnoff, Jens U. Marquardt |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/de919e8f156747908800041d56b6a7c0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
by: Sternschuss Michal, et al.
Published: (2021) -
Novel Methylation Biomarkers for Colorectal Cancer Prognosis
by: Alvaro Gutierrez, et al.
Published: (2021) -
Differential Expression of the Sphingolipid Pathway Is Associated with Sensitivity to the PP2A Activator FTY720 in Colorectal Cancer Cell Lines
by: Peter Sciberras, et al.
Published: (2021) -
Liver Transplantation for Non-Resectable Colorectal Liver Metastases
by: Ashwin Rammohan
Published: (2018) -
Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer
by: Chengwen Zhao, et al.
Published: (2021)